Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV

Condition:   Pulmonary Emphysema Intervention:   Device: The Pulmonx Zephyr Endobronchial Valve (EBV) 5.5- LP Sponsor:   Pulmonx Corporation Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Emphysema | Research